Drug profile · INN
polyestradiol phosphate
ESTRADURIN
polyestradiol phosphate (ESTRADURIN) is a estrogen receptor alpha agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — polyestradiol phosphate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
polyestradiol phosphate (ESTRADURIN) is a estrogen receptor alpha agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Estrogen receptor alpha agonist
Primary target: Estrogen receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is polyestradiol phosphate?
polyestradiol phosphate (ESTRADURIN) is a estrogen receptor alpha agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for polyestradiol phosphate?
ESTRADURIN is a marketed brand name for polyestradiol phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of polyestradiol phosphate?
polyestradiol phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.